红斑毛细血管扩张型玫瑰痤疮的治疗进展  

Advances in the treatment of erythematotelangiectatic rosaeca

作　　者：孙丽囡 尹兴平 刘伟[1] 陆晓君[1] 王娟娟 高远 SUN Li-Nan;YIN Xing-Ping;LIU Wei;LU Xiao-Jun;WANG Juan-Juan;GAO Yuan(Department of Dermatology,The People’s Hospital of SND,Jiangsu Province,215129,China)

机构地区：[1]苏州高新区人民医院皮肤科,江苏苏州215129

出　　处：《中国医疗美容》2022年第4期55-60,共6页China Medical Cosmetology

摘　　要：玫瑰痤疮是临床一种常见的面部的慢性炎症性皮肤病,病因复杂,容易复发,给患者的生活造成了巨大影响。临床上玫瑰痤疮可分为四型,红斑毛细血管扩张型玫瑰痤疮(erythematotelangiectatic rosacea,ETR)是其最常见的类型,目前治疗ETR的方法多种多样,包括外用药物治疗、口服药物治疗、光学治疗及注射治疗等,其有效性和安全性有待于临床进一步验证,本文将结合国内外研究对ETR的治疗进展进行综述。Rosacea is a common clinical chronic inflammatory dermatosis of the face,with complex etiology and easy recurrence,which has a huge impact on the life of patients.Clinically,rosacea can be divided into four types.Erythematotelangiectatic rosacea(ETR)is the most common type.At present,there are various methods for treating ETR,including topical drug therapy,oral drug therapy,photoelectric therapy and injection therapy.It,s efficacy and safety need to be further verified in clinical practice.This article will review the progress of ETR treatment combined with domestic and foreign research.

关 键 词：玫瑰痤疮 红斑毛细血管扩张型 治疗 

分 类 号：R758.734[医药卫生—皮肤病学与性病学]